Suppr超能文献

阿尔茨海默病抗炎研究的前沿和热点演进。

Frontiers and hotspots evolution in anti-inflammatory studies for Alzheimer's disease.

机构信息

Guangdong-HongKong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China.

Beijing University of Aeronautics and Astronautics, Beijing, China.

出版信息

Behav Brain Res. 2024 Aug 24;472:115178. doi: 10.1016/j.bbr.2024.115178. Epub 2024 Aug 3.

Abstract

BACKGROUND

Alzheimer's disease (AD) is a neurodegenerative disorder that seriously affects the quality of the elderly's lives worldwide. The main pathological features of AD are amyloid plaques formed by β-amyloid (Aβ) and neuronal fibrillary tangls (NFTs) formed by hyperphosphorylated Tau protein. The formation process of these pathological features is closely related to inflammatory response, so anti-inflammatory treatment has become a potential treatment for AD. In recent years, more and more research has shown that the anti-inflammatory therapy can relieve the symptoms of AD and improve cognitive function, which provides a valuable research direction for the treatment of AD strategy. Therefore, a comprehensive understanding of the hotspots and development trends of AD anti-inflammatory research is important for promoting the further development of this field and improving the quality of life of patients.

METHODS

This study used bibliometric methods, with AD and anti-inflammatory as key words, collected 7638 AD anti-inflammatory studies collected in Web of Science Core Collection (WoSCC) literature database since 2000, and conducted an in-depth analysis of the research hotspots and potential trends in this field.

RESULTS

The depth and breadth of AD anti-inflammatory research are in the stage of rapid development, and the hot focus is on exploring the role of inflammation in the pathogenesis of AD, especially the interaction of microglia in the neuroinflammatory mechanism. Secondly, the treatment effect and potential risks of anti-inflammatory drugs such as non-steroidal anti-inflammatory drugs (NSAIDs) on AD are also the focus of research. Therefore, researchers have carried out a series of animal experiments and prospective clinical studies on anti-inflammatory drugs for the treatment of AD, forming a comprehensive research system from basic research to clinical research. As for the future development trend, we believe that the further exploration of inflammation in the pathogenesis of AD will still be one of the key directions, and the application of big data and artificial intelligence technology is expected to provide strong support for the association between inflammation and AD progression. Moreover, the development of novel anti-inflammatory drugs for the inflammatory mechanism of AD will be another major trend for future research. At the same time, personalized treatment strategies and alternative supplements of medicine will also become one of the hotspots of future research. Through the comprehensive use of anti-inflammatory drugs, nutritional supplements, lifestyle intervention and other means, more comprehensive and effective treatment plans for AD patients are expected.

CONCLUSION

This research analyzes the overall development trend of AD anti-inflammatory research field since 2000, and provides a comprehensive perspective for the progress of AD anti-inflammatory research. Overall, the field of AD anti-inflammatory research is facing a broad development prospect. In the future, with further research and technological advances, we have resason to expect more effective and safer treatment options for AD patients to help them improve their quality of life and delay disease progression.

摘要

背景

阿尔茨海默病(AD)是一种神经退行性疾病,严重影响全球老年人的生活质量。AD 的主要病理特征是由β-淀粉样蛋白(Aβ)形成的淀粉样斑块和由过度磷酸化 Tau 蛋白形成的神经元纤维缠结(NFTs)。这些病理特征的形成过程与炎症反应密切相关,因此抗炎治疗已成为 AD 的潜在治疗方法。近年来,越来越多的研究表明,抗炎治疗可以缓解 AD 的症状并改善认知功能,这为 AD 治疗策略的进一步发展提供了有价值的研究方向。因此,全面了解 AD 抗炎研究的热点和发展趋势对于推动该领域的进一步发展和提高患者的生活质量非常重要。

方法

本研究采用文献计量学方法,以 AD 和抗炎为关键词,收集了 2000 年以来 Web of Science 核心合集(WoSCC)文献数据库中收录的 7638 篇 AD 抗炎研究文献,并对该领域的研究热点和潜在趋势进行了深入分析。

结果

AD 抗炎研究的深度和广度正处于快速发展阶段,热点集中在探索炎症在 AD 发病机制中的作用,特别是小胶质细胞在神经炎症机制中的相互作用。其次,非甾体抗炎药(NSAIDs)等抗炎药物对 AD 的治疗效果和潜在风险也是研究的重点。因此,研究人员对抗炎药物治疗 AD 进行了一系列动物实验和前瞻性临床研究,形成了从基础研究到临床研究的完整研究体系。至于未来的发展趋势,我们相信进一步探索 AD 发病机制中的炎症仍将是关键方向之一,大数据和人工智能技术的应用有望为炎症与 AD 进展之间的关联提供强有力的支持。此外,针对 AD 炎症机制的新型抗炎药物的开发也将成为未来研究的另一个主要趋势。同时,AD 患者的个性化治疗策略和替代药物补充也将成为未来研究的热点之一。通过综合使用抗炎药物、营养补充剂、生活方式干预等手段,有望为 AD 患者制定更全面、更有效的治疗方案。

结论

本研究分析了 2000 年以来 AD 抗炎研究领域的整体发展趋势,为 AD 抗炎研究的进展提供了全面的视角。总体而言,AD 抗炎研究领域正面临广阔的发展前景。未来,随着进一步的研究和技术进步,我们有理由期待为 AD 患者提供更有效、更安全的治疗选择,帮助他们提高生活质量并延缓疾病进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验